|
|
||||||||
Department of Pathology, University of Connecticut Health Center, Farmington, Connecticut 06032 and the Department of Pediatrics and Pathology, University of Minnesota College of Medicine, Minneapolis, Minnesota 55455
Abstract
Cytochalasin B (2 to 4 µg/ml) reversibly inhibits the chemotactic response of human and rabbit polymorphonuclear leukocytes to a bacterial chemotactic factor or to the complement derived factor, C5a. At lower concentrations (1 to 0.1 µg/ml or less) Cytochalasin B actually stimulates chemotaxis. Spontaneous movement of the leukocyte is reversibly inhibited at concentrations as low as 0.2 µg/ml. Enhancement of the spontaneous motility has not been observed at this or lower concentrations.
Footnotes
1 This study was supported by United States Public Health Service Grant AI-09648 to E. L. B., and in part by United States Public Health Service Grants AI-08821 and AI-06931 and in part by a grant from the Minnesota Arthritis Foundation, the United States Army Medical Research and Development Command under Contract No. DADA 17-69-C-9182 and the Elsa U. Pardee Foundation.
This article has been cited by other articles:
![]() |
M. H. Hsu, S. C. Chiang, R. D. Ye, and E. R. Prossnitz Phosphorylation of the N-Formyl Peptide Receptor Is Required for Receptor Internalization but Not Chemotaxis J. Biol. Chem., November 21, 1997; 272(47): 29426 - 29429. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Catsimpoolas, Kurtz SR, E. Skrabut, A. Griffith, and C. Valeri Cytotaxins after the sedimentation behavior of human granulocytes Science, August 31, 1979; 205(4409): 936 - 937. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |